Companies Cryptocurrencies
Inmode Ltd
Inmode Ltd
Exchange: NasdaqGS
IPO Date: 08/08/2019
CEO: Mr. Moshe Mizrahy
Medical Devices Healthcare đź”—
  • INMD
  • 176.48
  • 6739930112
    market cap
  • 5.4299927
If you bought

shares of Inmode Ltd (INMD) on
You would have made
Old Price $12 Current Price $12

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. The company designs, develops, manufactures and commercializes energy-based, minimally-invasive surgical aesthetic and medical treatment solutions. The Company’s proprietary technologies are used by physicians to remodel subdermal adipose, or fatty, tissue in a variety of procedures including fat reduction with simultaneous skin tightening, face and body contouring and ablative skin rejuvenation treatments. Its products target a wide array of procedures including simultaneous fat killing and skin tightening, permanent hair reduction, skin appearance and texture, among others. The Company’s products may be used on a variety of body parts, including the face, neck, abdomen, upper arms, thighs and intimate feminine regions. The company owns six product platforms: BodyTite, Optimas, Votiva, Contoura, Triton and EmbraceRF. All are market and sell traditionally to plastic and facial surgeons, aesthetic surgeons and dermatologists, among others.

Address: Tavor Building Sha'ar Yokneam Pob 533 YOKNEAM 2069206

Stay updated.